Seizure-free Days Observed in Randomized Placebo-controlled Add-on Trials with Levetiracetam in Partial Epilepsy
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-10-01
著者
-
Morrell Martha
The Neurological Institute Columbia University
-
LEPPIK Ilo
MINCEP Epilepsy Care and University of Minnesota
-
ARRIGO Celestina
UCB Pharma, Outcomes Research
-
Leppik Ilo
Mincep Epilepsy Care
-
GODFROID Philippe
UCB Pharma, Outcomes Research
-
Godfroid Philippe
Ucb Pharma Outcomes Research
-
Arrigo Celestina
Ucb Pharma Outcomes Research
関連論文
- Status Epilepticus and Tiagabine Therapy : Review of Safety Data and Epidemiologic Comparisons
- Safety and Tolerability of Gabapentin as Adjunctive Therapy in a Large, Multicenter Study
- Fast and Sustained Efficacy of Levetiracetam during Titration and the First 3 Months of Treatment in Refractory Epilepsy
- Rapid Onset of Action of Levetiracetam in Refractory Epilepsy Patients
- Role of New and Established Antiepileptic Drugs
- Classification of the Myoclonic Epilepsies
- The Place of Levetiracetam in the Treatment of Epilepsy
- Tiagabine: The Safety Landscape
- Levetiracetam and Partial Seizure Subtypes : Pooled Data from Three Randomized, Placebo-controlled Trials
- Felbamate
- Seizure-free Days Observed in Randomized Placebo-controlled Add-on Trials with Levetiracetam in Partial Epilepsy
- Issues in the Treatment of Epilepsy